2016
Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment
Shrestha R, Huedo-Medina TB, Altice FL, Krishnan A, Copenhaver M. Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment. AIDS And Behavior 2016, 21: 3100-3110. PMID: 28025735, PMCID: PMC5484759, DOI: 10.1007/s10461-016-1637-x.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultCell PhoneConnecticutDelivery of Health CareDrug UsersFemaleHIV InfectionsHumansInternetMaleMethadoneNeurocognitive DisordersOpiate Substitution TreatmentPatient Acceptance of Health CarePrevalenceRisk FactorsRisk-TakingSexual BehaviorSmartphoneSubstance Abuse, IntravenousTelemedicineText MessagingConceptsSex-related risk behaviorsNeurocognitive impairmentDrug usersRisk behaviorsHIV-negative drug usersHigh-risk drug usersHigh-risk populationHigh-risk peopleHIV prevention effortsUse of mHealthMethadone clinicsHIV preventionHigh prevalenceMedication remindersHealth programsMHealth acceptancePrevention effortsHealth conditionsMHealth technologiesConvenience sampleDrugsStandardized assessmentReal-world acceptanceMobile healthPhone calls
2002
Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives
Broadhead R, Kerr T, Grund J, Altice F. Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives. Journal Of Drug Issues 2002, 32: 329-355. DOI: 10.1177/002204260203200113.Peer-Reviewed Original ResearchSafer injection facilityHealth initiativesDrug treatmentInjection-related health problemsNeedle exchange programsDrug-using communityPublic health initiativesPublic health programsHealth care programsDrug injectionDrug overdoseDrug injectorsMortality rateCare programNeedle exchangeHealth problemsMedical careHealth programsInjection facilitiesInnovative interventionsTimely contactTreatmentHCVHIVOverdose